Nitisinone, a drug for uncommon ailments, kills mosquitoes when current in human blood and will grow to be a brand new device to struggle malaria, providing longer-lasting, environmentally safer results than ivermectin.
Controlling mosquito populations is a key technique within the struggle in opposition to malaria.
At present, a number of approaches are used to scale back mosquito numbers and restrict malaria transmission. One technique entails the usage of the antiparasitic drug ivermectin. When mosquitoes feed on blood containing ivermectin, their lifespan is shortened, which may scale back the unfold of the malaria parasite.
Nonetheless, ivermectin presents challenges. It’s poisonous to the setting, and its widespread use in each people and animals to deal with parasitic infections raises the chance of drug resistance.
Now, a research revealed in Science Translational Medication has recognized a promising various. Researchers found that when folks take the treatment nitisinone, their blood turns into deadly to mosquitoes, providing a possible new device for mosquito management and malaria prevention.
How Nitisinone Works
“One strategy to cease the unfold of ailments transmitted by bugs is to make the blood of animals and people poisonous to those blood-feeding bugs,” stated Lee R. Haines, affiliate analysis professor of organic sciences on the College of Notre Dame, honorary fellow on the Liverpool College of Tropical Medication and co-lead creator of the research. “Our findings recommend that utilizing nitisinone could possibly be a promising new complementary device for controlling insect-borne ailments like malaria.”
Usually, nitisinone is a medicine for people with uncommon inherited ailments — akin to alkaptonuria and tyrosinemia kind 1 — whose our bodies battle to metabolize the amino acid tyrosine. The treatment works by blocking the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD), stopping the build-up of dangerous illness byproducts within the human physique. When mosquitoes drink blood that accommodates nitisinone, the drug additionally blocks this important HPPD enzyme of their our bodies. This prevents the mosquitoes from correctly digesting the blood, inflicting them to rapidly die.
The researchers analyzed the nitisinone dosing concentrations wanted for killing mosquitoes, and the way these outcomes would stack up in opposition to ivermectin, the gold commonplace ectoparasitic drug (treatment that particularly targets ectoparasites akin to mosquitoes).
“We thought that if we wished to go down this route, nitisinone needed to carry out higher than ivermectin,” stated Álvaro Acosta Serrano, professor of organic sciences at Notre Dame and co-corresponding creator of the research. “Certainly, nitisinone efficiency was unbelievable; it has a for much longer half-life in human blood than ivermectin, which implies its mosquitocidal exercise stays circulating within the human physique for for much longer. That is crucial when utilized within the discipline for security and economical causes.”
Testing Nitisinone in People
The analysis group examined the mosquitocidal impact of nitisinone on feminine Anopheles gambiae mosquitoes, the first mosquito species chargeable for spreading malaria in lots of African international locations. If these mosquitoes grow to be contaminated with malaria parasites, they unfold the illness once they feast on a human.
To judge how the drug affected the mosquitoes when fed contemporary human blood containing nitisinone, researchers collaborated with the Robert Gregory Nationwide Alkaptonuria Centre on the Royal Liverpool College Hospital. The middle was performing nitisinone trials with folks identified with alkaptonuria, who then donated their blood for the research. These taking nitisinone have been discovered to have blood that was lethal to mosquitoes, which Haines describes as having a “hidden superpower.”
The analysis group collected knowledge on how the drug was metabolized in peoples’ blood, permitting the group to fine-tune their modeling and supply pharmacological validation of nitisinone as a possible mosquito inhabitants management technique.
Nitisinone was proven to last more than ivermectin within the human bloodstream, and was capable of kill not solely mosquitoes of all ages — together with the older ones which are most certainly to transmit malaria — but in addition the hardy mosquitoes proof against conventional pesticides.
“Sooner or later, it could possibly be advantageous to alternate each nitisinone and ivermectin for mosquito management,” Haines stated. “For instance, nitisinone could possibly be employed in areas the place ivermectin resistance persists or the place ivermectin is already closely used for livestock and people.”
Subsequent Steps and Broader Impacts
Subsequent, the analysis group goals to discover a semi-field trial to find out what nitisinone dosages are greatest linked to mosquitocidal efficacy within the discipline.
“Nitisinone is a flexible compound that can be used as an insecticide. What’s notably attention-grabbing is that it particularly targets blood-sucking bugs, making it an environmentally pleasant choice,” Acosta Serrano stated.
As an unintended profit, extending the usage of nitisinone as a vector management device may consequently improve drug manufacturing and reduce the worth of the treatment for sufferers affected by uncommon genetic ailments within the tyrosine metabolism pathway.
Reference: “Anopheles mosquito survival and pharmacokinetic modeling present the mosquitocidal exercise of nitisinone” by Lee R. Haines, Anna Trett, Clair Rose, Natalia García, Marcos Sterkel, Dagmara McGuinness, Clément Regnault, Michael P. Barrett, Didier Leroy, Jeremy N. Burrows, Giancarlo Biagini, Lakshminarayan R. Ranganath, Ghaith Aljayyoussi and Álvaro Acosta-Serrano, 26 March 2025, Science Translational Medication.
DOI: 10.1126/scitranslmed.adr4827
The research was funded by the UK Medical Analysis Council, Biotechnology and Organic Sciences Analysis Council, Wellcome Belief Institutional Strategic Help Fund, the Medical Analysis Council Doctoral Coaching Partnership and the College of Glasgow Wellcome Centre for Integrative Parasitology.
